Category - Executive Moves

Executive Moves

Joseph Pantginis joins Rodman

Joseph Pantginis has joined Rodman & Renshaw in equity research as a managing director covering biotechnology.

January 5, 2017

Executive Moves

Titan Pharma adds two members to BOD

Titan Pharmaceuticals (NASDAQ:TTNP), in a move to boost its product development and commercialization experience in the U.S., Europe and Asia, named Scott Smith and Dr. Rajinder Kumar to its board.

January 4, 2017

Executive Moves

Cantor expands healthcare and biotech research

Cantor Fitzgerald has expanded its healthcare equity research team with the addition of Bill Tanner as a senior research analyst covering biotechnology and Steven Halper as a senior research analyst covering healthcare...

December 16, 2016

Executive Moves

Aurinia Pharma names Jeffry Randal to board

Aurinia Pharmaceuticals (NASDAQ:AUPH; TSX:AUP) appointed Lorin Jeffry Randall to its board and chairman of the audit committee.

December 13, 2016

Executive Moves

3DS names Helen Stevenson to board, Ian Smith to CSAB

3D Signatures (TSX-V:DXD) named Helen Stevenson to the board and Ian Smith, who is stepping down from the board, to the clinical and scientific advisory board (CSAB).

December 9, 2016

Executive Moves

Nigel Terrett joins 3DS business advisory board

3D Signatures (TSX-V:DXD) has appointed Nigel Terrett to 3DS's business advisory board to provide the company with strategic insight and guidance related to commercial lab partnerships and information technology...

December 5, 2016

Executive Moves

Jeff Sacher joins Aegis to lead firm’s healthcare banking

Jeff Sacher has joined Aegis Capital to lead the firm's global healthcare effort as a managing director.Previously, Mr. Sacher was a senior banker at Goldman Sachs, Needham and Brean Capital. In addition, he has served...

November 8, 2016

Executive Moves

Microbix names Jim Currie as CFO

Microbix Biosystems (TSX:MBX) appointed Jim Currie as CFO, succeeding Charles Wallace, who is retiring at the end of the year.Mr. Currie was most recently CFO of SMTC, a global electronics manufacturing services company...

November 1, 2016

Executive Moves

Jason Flowerday named CEO of 3D Signatures

3D Signatures (TSX-V:DXD) has appointed Jason Flowerday as CEO. He succeeds Ferenc Somogyvari, who will remain on the board."Mr. Flowerday is a highly respected biotech entrepreneur with more than 20 years of executive...

September 27, 2016

Executive Moves

Stereotaxis strengthens financial position, expands Board of Directors

Stereotaxis (NASDAQ:STXS) has signed definitive agreements for multiple transactions that significantly strengthen its financial position and help accelerate and enhance its strategic market growth initiatives.The...

September 27, 2016

Category - Executive Moves

Joseph Pantginis joins Rodman

Titan Pharma adds two members to BOD

Cantor expands healthcare and biotech research

Aurinia Pharma names Jeffry Randal to board

3DS names Helen Stevenson to board, Ian Smith to CSAB

Nigel Terrett joins 3DS business advisory board

Jeff Sacher joins Aegis to lead firm’s healthcare banking

Microbix names Jim Currie as CFO

Jason Flowerday named CEO of 3D Signatures

Stereotaxis strengthens financial position, expands Board of Directors

General

More